TY - JOUR T1 - Presence Of Infection By <em>Mycobacterium Avium</em> Subsp. <em>Paratuberculosis</em> In The Blood Of Patients With Crohn’s Disease And Control Subjects Shown By Multiple Laboratory Culture And Antibody Methods JF - medRxiv DO - 10.1101/2020.10.12.20209221 SP - 2020.10.12.20209221 AU - J. Todd Kuenstner AU - Raghava Potula AU - Tim J. Bull AU - Irene R. Grant AU - Antonio Foddai AU - Saleh Naser AU - Horacio Bach AU - Peilin Zhang AU - Daohai Yu AU - Xiaoning Lu AU - Ira Shafran Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/14/2020.10.12.20209221.abstract N2 - Mycobacterium avium subspecies paratuberculosis (MAP) has long been suspected to be involved in the etiology of Crohn’s disease (CD). An obligate intracellular pathogen, MAP persists and influences host macrophages. The primary goals of this study were to assess the degree of viable culturable MAP bacteremia in humans, definite identification of the organisms cultured and to assess if CD patients have a significantly higher rate of MAP infection compared to controls. A secondary goal was to compare the efficacy of three culture methods plus a phage assay and four antibody assays performed in separate laboratories, to detect MAP from the parallel samples. Culture and serological MAP testing was performed blind on whole blood samples obtained from 201 subjects including 61 CD patients, two patients with CD and concurrent ulcerative colitis (UC), 14 patients with UC only and 140 non-CD controls. Viable MAP bacteremia was detected in a significant number of study subjects across all groups. This included Pozzato culture (124/201 or 62% of all subjects, 35/61 or 57% of CD patients), Phage assay (113/201 or 56% of all subjects, 28/61 or 46% of CD patients), TiKa culture (64/201 or 32% of all subjects, 22/61 or 36% of CD patients) and MGIT culture (36/201 or 18% of all subjects, 15/61 or 25% of CD patients). A link between MAP detection and CD was observed with MGIT culture and one of the antibody methods (Hsp65) confirming previous studies. Other detection methods showed no association between any of the groups tested. Nine subjects with positive Phage assay (8/9) or MAP culture (1/9) were again positive with the Phage assay one year later. This study highlights viable MAP bacteremia is widespread in the study population including CD patients, those with other autoimmune conditions and asymptomatic healthy subjects.Competing Interest StatementTim J. Bull is a director of TiKa Diagnostics Ltd, a manufacturer of the TiKa mycobacterial growth supplements used in this study. Grant, Foddai, Kuenstner, Potula, Bull, Naser and Shafran have a proprietary interest in a pending patent for the phage assay. Kuenstner, Potula, Bach and Zhang have a proprietary interest in a pending patent for MAP antibody assays.Funding StatementThis study was supported by the Human Paratuberculosis Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was reviewed by the Temple University IRB and was considered exempt.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analysed during this study are included in this published article. ER -